APA (7th ed.) Citation

O, K., A, V., A, U., I, Y., NC, B., A, K., . . . E, G. (2025). Long-term metabolic and safety profiles of tenofovir alafenamide and tenofovir disoproxil fumarate in ART-naive people living with HIV: A multicenter retrospective study using a mixed-effects model. BMC pharmacology & toxicology, 26(1), 164. https://doi.org/10.1186/s40360-025-01003-0

Chicago Style (17th ed.) Citation

O, Karabay, et al. "Long-term Metabolic and Safety Profiles of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in ART-naive People Living with HIV: A Multicenter Retrospective Study Using a Mixed-effects Model." BMC Pharmacology & Toxicology 26, no. 1 (2025): 164. https://doi.org/10.1186/s40360-025-01003-0.

MLA (9th ed.) Citation

O, Karabay, et al. "Long-term Metabolic and Safety Profiles of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in ART-naive People Living with HIV: A Multicenter Retrospective Study Using a Mixed-effects Model." BMC Pharmacology & Toxicology, vol. 26, no. 1, 2025, p. 164, https://doi.org/10.1186/s40360-025-01003-0.